Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — shareholding pattern, promoter holding, financials and share price

About Apollo Hospitals Enterprise Ltd (APOLLOHOSP)

Apollo Hospitals Enterprise Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as APOLLOHOSP and on the BSE under scrip code 508869. Its ISIN is INE437A01024.

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Apollo Hospitals Enterprise Ltd is a pan‑India integrated healthcare provider operating hospitals, diagnostics, primary care clinics, an omni‑channel pharmacy distribution network and a large digital healthcare platform, with a consolidated network that includes 76 hospitals, ~10,325 capacity beds and material subsidiaries Apollo HealthCo and AHLL delivering out‑of‑hospital care and retail diagnostics.

Q3 FY26 consolidated revenues grew 17% year‑on‑year to ₹64,774 million with EBITDA up 27% to ₹9,653 million and PAT up 35% to ₹5,023 million, driven by 14% healthcare services growth, 20% HealthCo revenue growth and AHLL diagnostics expansion; digital losses narrowed significantly and HealthCo cash profit doubled versus prior year.

Listed peers in Hospital: Max Healthcare Institute Ltd, Fortis Healthcare Ltd, Aster DM Healthcare Ltd, Narayana Hrudayalaya Ltd, Global Health Ltd, Krishna Institute of Medical Sciences Ltd.

Valuation & Returns

10 Jul 2026

At ₹8,843.7 a share on 10 Jul 2026, Apollo Hospitals Enterprise Ltd (APOLLOHOSP) was valued at a price-to-earnings ratio of 63.5x against an industry P/E of 61.73x and a price-to-book of 15.48x on a book value of ₹571.15 per share as of Mar 2025. Solomo computes return on equity of 24.39% and return on capital employed of 19.35% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
63.5x
Industry P/E
61.73x
P/B
15.48x
EPS (TTM)
₹139.28
Book value / share
₹571.15
ROE
24.39%
ROCE
19.35%
ROA
9.69%
Debt / equity
0.96x
Dividend yield
0.23%
EBITDA margin
15.8%
52-week range
₹6,680 – ₹8,948.1

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Apollo Hospitals Enterprise Ltd (APOLLOHOSP) reported revenue of ₹25,228 crore, net profit of ₹2,003 crore and earnings per share of ₹135.04. That compares with revenue of ₹21,794 crore and net profit of ₹1,505 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹6,606 crore and net profit ₹551 crore (consolidated).

Consolidated annual results for Apollo Hospitals Enterprise Ltd (APOLLOHOSP), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)14,66316,61219,05921,79425,228
Net profit (₹ cr)1,1088449351,5052,003
EPS (₹)73.4256.9762.5100.56135.04
Compound annual growth for Apollo Hospitals Enterprise Ltd (APOLLOHOSP). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth4.36%-3.49%10.38%14.35%
Profit growth16.26%22.49%31.31%60.97%
Stock price CAGR21%19%19%21%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 28.02% of Apollo Hospitals Enterprise Ltd (APOLLOHOSP) (unchanged from the previous quarter), foreign institutional investors (FII) hold 41.5% and domestic institutional investors (DII) hold 23.72%. Promoters have pledged 2.5% of their holding. Market capitalisation was ₹1,27,159 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.

Largest disclosed public shareholders in Jun 2026: SBI NIFTY 50 ETF 2.32%, LIFE INSURANCE CORPORATION OF INDIA 1.97%, AXIS MUTUAL FUND TRUSTEE LIMITED 1.79%, GOVERNMENT PENSION FUND GLOBAL 1.64%, MIRAE ASSET ELSS TAX SAVER FUND 1.5%, ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED 1.39%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202628.02%2.5%41.5%23.72%71.98%
Mar 202628.02%2.5%42.62%22.76%71.98%
Dec 202528.02%2.5%43.54%21.51%71.98%
Sep 202528.02%8.6%44.2%21.12%71.98%
Jun 202529.34%13.1%43.49%21.34%70.66%
Mar 202529.34%13.5%42.74%22.29%70.66%
Dec 202429.33%13.5%45.27%19.98%70.67%
Sep 202429.33%14%45.37%19.95%70.67%